HIGHLIGHTS
- who: Top from the OREGA Biotech, Ecully, France Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff, XN, UK have published the paper: The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2, in the Journal: (JOURNAL)
- how: Survival data were compared using the log-rank test. Data were analyzed using the Flowjo 10 software.
SUMMARY
IL-17B promotes the recruitment of macrophages that, in turn, favors cancer cell survival and invasion as well as the recruitment of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.